Results 161 to 170 of about 16,238 (237)

Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]

Mater Today Bio
Yang L, Chen G, Lyu Z.
europepmc   +1 more source

Exploring the Role of Canakinumab in the Treatment of Autoinflammatory Bone Disorders: A Systematic Review [PDF]

Lisa Gamalero, Teresa Giani
openalex   +1 more source

Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0-16: a comprehensive analysis based on FAERS data. [PDF]

Pediatr Rheumatol Online J
Xiao P, Wei B, Zhang G, Zhang X, Wan H, Qi Y, Chen L, Huang Y, Liu J.   +8 more
europepmc   +1 more source

Treatment of Erdheim–Chester disease with canakinumab [PDF]

, 2014
Tú-Anh Tran, Danièle Pariente, Corinne Guitton, Adriana Delwail, Mouna Barat‐Houari, Ulrich Meinzer   +5 more
openalex   +1 more source

ABS1133 INDICATIONS, EFFICACY, AND SAFETY OF CANAKINUMAB: REAL LIFE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CLINIC

R. Deniz, Özgür Altun, Şule Gök, Celal Yavuz, H.K. Yerişenoğlu Demir, F. Deniz, Ramazan Altıntaş, Kader Uğur, Ayşe Elif Boncukçuoğlu, Bilgin Karaalioğlu, Gülcihan Akkuzu, D.S. Ozgur, Funda Yıldırım, Can Erzık, C. Bes   +14 more
openalex   +1 more source

Budget Impact Analysis of Inclusion in the Expensive Drugs List of Canakinumab for Treatment of Systemic Onset Juvenile Arthritis [PDF]

, 2019
E.V. Derkach
openalex   +1 more source

Pharmacologic management of renal involvement in monogenic autoinflammatory diseases. [PDF]

Eur J Med Res
Fayed A, Hegazy MT, Sota J, Gaggiano C, Ragab G.   +4 more
europepmc   +1 more source

Canakinumab in adults with steroid‐refractory pyoderma gangrenosum [PDF]

, 2015
Antonios G.A. Kolios, Julia‐Tatjana Maul, Barbara Meier, Katrin Kerl, Claudia Traidl‐Hoffmann, Michael Hertl, Detlef Zillikens, Martin Röcken, Johannes Ring, Antonio Facchiano, Chiara Mondino, Nikhil Yawalkar, Emmanuel Contassot, Alexander A. Navarini, Lars E. French   +14 more
openalex   +1 more source

Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke [PDF]

, 2018
Luca Liberale, Candela Díaz-Cañestro, Nicole R. Bonetti, Francesco Paneni, Alexander Akhmedov, Jürg H. Beer, Fabrizio Montecucco, Thomas F. Lüscher, Giovanni G. Camici   +8 more
openalex   +1 more source

Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset [PDF]

, 2014

core   +1 more source